- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05723419
Prediction of Clinical Outcome in Axillary Block
Perfusion Index Value in Predicting the Clinical Outcome of Axillary Block
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The interscalene brachial plexus block is an effective intervention for reducing postoperative pain but is related to side effects, Suprascapular nerve block and a block of the axillary nerve have been introduced as alternatives to the interscalene brachial plexus for the control of postoperative pain. Previous study demonstrated new method of axillary block using interfascial plane injection guided by ultrasoud. Axillary block has been used widely for the relief of postoperative arm pain.
Recent study deomonstrated good pain relief when ultrasound guided fascial plane injection was performed in patients with cervical radiuculopathy.
The perfusion index (PI) is a numerical value for the ratio between pulsatile and non-pulsatile blood flow measured by a special pulse oximeter. Although the special probe for PI measurement is relatively more expensive compared with ordinary pulse oximetery probes, its benefit as a marker of peripheral perfusion and as an idex for sympathetic stimulation have increased its use progressively. PI has been used widely for the prediction of success of brachial plexus block or axillary block. Changes of PI ratio value showed an excellent predictive value for the success of block.
There have been no studies demonstrating any predictive value of PI in axillary block for the relief of cervical radiulopathy
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Daegu, Korea, Republic of, 42601
- Recruiting
- Ji Hoon Park
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Cervical foraminal stenosis
- Cervical central stenosis
- Cervical disc herniation
- Cervical spondylolisthesis
Exclusion Criteria:
- Infection
- pregnancy
- allergy to local anesthetic agents
- previous cervical spine surgery
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perfusion index changes among 4 time periods
Time Frame: baseline, 10 minutes, 20 minutes, 30 minutes after axillary block
|
Perfusion index changes among 4 time periods
|
baseline, 10 minutes, 20 minutes, 30 minutes after axillary block
|
|
Number of patients showing numerical rating scale reduction more than 50%
Time Frame: 1 month after axillary block
|
Number of patients showing numerical rating scale reduction more than 50%
|
1 month after axillary block
|
|
Number of patients showing numerical rating scale reduction less than 50%
Time Frame: 1 month after axillary block
|
Number of patients showing numerical rating scale reduction less than 50%
|
1 month after axillary block
|
|
Number of patients showing no reduction in numerical rating scale
Time Frame: 1 month after axillary block
|
Number of patients showing no reduction in numerical rating scale
|
1 month after axillary block
|
|
Neck disability index changes between 2 time periods
Time Frame: baseline, 1 month after axillary block
|
Neck disability index changes between 2 time periods
|
baseline, 1 month after axillary block
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20201-025-04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.